Skip to main content
. 2021 Jan 15;18(2):701. doi: 10.3390/ijerph18020701

Figure 2.

Figure 2

Observed survival of patients with chronic lymphocytic leukemia by the Charlson comorbidity index at diagnosis. Events included both types of death, CLL-related and CLL-unrelated. The differences between the survival curves that had a p-value <0.05 were considered to be statistically significant.